We are live on ! Find out more
MIRM icon

Mirum Pharmaceuticals
MIRM

67 hedge funds and large institutions have $405M invested in Mirum Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 23 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 3

10% more funds holding

Funds holding: 61 → 67 (+6)

0.02% more ownership

Funds ownership: 76.83% → 76.86% (+0.02%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

9% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 23

13% less capital invested

Capital invested by funds: $463M → $405M (-$58.6M)

Holders
67
Holders Change
+6
Holders Change %
+9.84%
% of All Funds
1.17%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
10
Increased
21
Reduced
23
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$4.27M
2
Axa
Axa
France
+$1.66M
3
Renaissance Technologies
Renaissance Technologies
New York
+$885K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$885K
5
Morgan Stanley
Morgan Stanley
New York
+$798K

Top Sellers

1
SI
Sofinnova Investments
California
-$3.89M
2
BlackRock
BlackRock
New York
-$2.74M
3
DCM
Driehaus Capital Management
Illinois
-$2.56M
4
Millennium Management
Millennium Management
New York
-$679K
5
RJA
Raymond James & Associates
Florida
-$358K
Name Holding Trade Value Shares
Change 		Change in
Stake
NMC
1
NEA Management Company
Maryland
$72.4M – – –
FM
2
Frazier Management
Washington
$61.7M – – –
DM
3
Deerfield Management
New York
$59.6M – – –
NHAS
4
Novo Holdings A/S
Denmark
$42.3M – – –
RVM
5
RiverVest Venture Management
Missouri
$33.2M – – –
RSCM
6
Rock Springs Capital Management
Maryland
$26.3M +$375K +20,923 +1%
Vanguard Group
7
Vanguard Group
Pennsylvania
$12.6M -$168K -9,377 -1%
Axa
8
Axa
France
$11.4M +$1.66M +92,610 +16%
BBA
9
Baker Bros. Advisors
New York
$11.2M – – –
BlackRock
10
BlackRock
New York
$10.5M -$2.74M -153,105 -20%
SCM
11
Sio Capital Management
New York
$7.87M +$318K +17,754 +4%
DCM
12
Driehaus Capital Management
Illinois
$6.45M -$2.56M -143,128 -28%
Wellington Management Group
13
Wellington Management Group
Massachusetts
$5.98M +$4.27M +238,300 +221%
BC
14
Boxer Capital
California
$5.48M – – –
SI
15
Sofinnova Investments
California
$4.49M -$3.89M -216,936 -46%
BCM
16
Burrage Capital Management
Massachusetts
$3.56M – – –
Geode Capital Management
17
Geode Capital Management
Massachusetts
$3.01M +$33K +1,841 +1%
Ensign Peak Advisors
18
Ensign Peak Advisors
Utah
$2.19M – – –
State Street
19
State Street
Massachusetts
$2.17M +$630K +35,168 +39%
Fidelity Investments
20
Fidelity Investments
Massachusetts
$1.98M – – –
Northern Trust
21
Northern Trust
Illinois
$1.66M -$17.1K -957 -1%
Two Sigma Investments
22
Two Sigma Investments
New York
$1.62M -$37.7K -2,105 -2%
Two Sigma Advisers
23
Two Sigma Advisers
New York
$1.41M +$226K +12,600 +18%
Deutsche Bank
24
Deutsche Bank
Germany
$1.39M -$22.2K -1,237 -2%
Charles Schwab
25
Charles Schwab
California
$1.3M -$16.1K -899 -1%
1
2 3

MIRM Hedge Fund Activity: Q2 2021 in Review

67 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Mirum Pharmaceuticals (MIRM) for Q2 2021, worth a combined $405M — down 13% from $463M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new MIRM positions and 3 closed out — a net gain of 7 holders — while 21 added to existing stakes and 23 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $4.27M. The largest seller was Sofinnova Investments, cutting an estimated $3.89M.

  • 67 institutional investors held Mirum Pharmaceuticals (MIRM) as of Q2 2021, up from 61 in Q1 2021.
  • Funds reported $405M of Mirum Pharmaceuticals stock for Q2 2021, down 13% quarter-over-quarter.
  • 10 funds opened new Mirum Pharmaceuticals positions in Q2 2021 and 3 closed out, a net change of +7 holders.
  • The largest Mirum Pharmaceuticals buyer in Q2 2021 was Wellington Management Group, an estimated $4.27M added.
  • The largest Mirum Pharmaceuticals seller in Q2 2021 was Sofinnova Investments, an estimated $3.89M sold.

Based on aggregated 13F filings for Q2 2021.